BioCentury
ARTICLE | Clinical News

ALN-PCSsc: Phase II started

February 15, 2016 8:00 AM UTC

The Medicines Co. began the double-blind, placebo-controlled, international Phase II ORION-1 trial to evaluate single or multiple, quarterly or biannual subcutaneous ALN-PCSsc in about 480 patients wi...